Auxly Historical Income Statement

XLY Stock

CAD 0.03 0.01 14.29%

Historical analysis of Auxly Cannabis income statement accounts such as Depreciation And Amortization of 11.8 M, Interest Expense of 26.9 M, Total Revenue of 106.1 M or Other Operating Expenses of 150.4 M can show how well Auxly Cannabis Group performed in making a profits. Evaluating Auxly Cannabis income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Auxly Cannabis's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Auxly Cannabis Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Auxly Cannabis Group is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Auxly Cannabis Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Auxly Income Statement Analysis

Auxly Cannabis Group Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Auxly Cannabis shareholders. The income statement also shows Auxly investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Auxly Cannabis Income Statement Chart

At this time, Auxly Cannabis' Depreciation And Amortization is very stable compared to the past year. As of the 23rd of December 2024, Interest Expense is likely to grow to about 26.9 M, though Gross Profit is likely to grow to (1.8 M).

Total Revenue Other Operating Expenses Total Operating Expenses Selling General Administrative Interest Income

Total Revenue

Total revenue comprises all receipts Auxly Cannabis Group generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Auxly Cannabis Group. It is also known as Auxly Cannabis overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Most accounts from Auxly Cannabis' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Auxly Cannabis Group current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Auxly Cannabis Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Total Revenue	83.8M	94.5M	101.1M	106.1M
Interest Expense	17.7M	21.6M	25.7M	26.9M

Total Revenue Interest Expense

Auxly Cannabis income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Cost Of Revenue	Selling And Marketing Expenses	Tax Provision	Interest Income	Net Interest Income	Net Income From Continuing Ops	Research Development	Reconciled Depreciation	Minority Interest	Discontinued Operations	Extraordinary Items
Depreciation And Amortization		0.88	0.89	0.66	0.93	-0.76	-0.77	-0.61	0.85	-0.81	-0.73	-0.8	-0.68	0.68	0.84	0.81	-0.68	0.21	-0.88	-0.78	-0.84	1.0	-0.69	0.82	0.49
Interest Expense	0.88		0.93	0.34	0.99	-0.82	-0.82	-0.72	0.83	-0.7	-0.47	-0.7	-0.6	0.71	0.94	0.7	-0.61	0.2	-0.98	-0.64	-0.91	0.87	-0.65	0.88	0.39
Total Revenue	0.89	0.93		0.5	0.95	-0.61	-0.63	-0.47	0.68	-0.53	-0.38	-0.53	-0.41	0.49	0.99	0.79	-0.42	0.03	-0.97	-0.48	-0.75	0.88	-0.58	0.95	0.5
Gross Profit	0.66	0.34	0.5		0.47	-0.35	-0.36	-0.21	0.53	-0.45	-0.48	-0.47	-0.19	0.38	0.36	0.7	-0.18	0.22	-0.37	-0.46	-0.41	0.68	-0.39	0.41	0.66
Other Operating Expenses	0.93	0.99	0.95	0.47		-0.82	-0.83	-0.71	0.86	-0.73	-0.53	-0.73	-0.61	0.73	0.94	0.77	-0.61	0.26	-0.98	-0.67	-0.91	0.92	-0.71	0.87	0.45
Operating Income	-0.76	-0.82	-0.61	-0.35	-0.82		1.0	0.98	-0.98	0.91	0.65	0.91	0.76	-0.98	-0.6	-0.54	0.76	-0.65	0.72	0.85	0.96	-0.76	0.8	-0.48	-0.28
Ebit	-0.77	-0.82	-0.63	-0.36	-0.83	1.0		0.97	-0.98	0.91	0.66	0.91	0.77	-0.97	-0.61	-0.56	0.77	-0.65	0.73	0.85	0.96	-0.77	0.82	-0.49	-0.29
Ebitda	-0.61	-0.72	-0.47	-0.21	-0.71	0.98	0.97		-0.92	0.85	0.56	0.85	0.72	-0.97	-0.47	-0.41	0.72	-0.73	0.6	0.78	0.91	-0.61	0.78	-0.33	-0.19
Total Operating Expenses	0.85	0.83	0.68	0.53	0.86	-0.98	-0.98	-0.92		-0.93	-0.71	-0.93	-0.76	0.96	0.64	0.66	-0.75	0.59	-0.75	-0.87	-0.96	0.85	-0.79	0.56	0.41
Income Before Tax	-0.81	-0.7	-0.53	-0.45	-0.73	0.91	0.91	0.85	-0.93		0.91	1.0	0.83	-0.9	-0.49	-0.56	0.82	-0.58	0.62	0.99	0.85	-0.81	0.76	-0.4	-0.15
Total Other Income Expense Net	-0.73	-0.47	-0.38	-0.48	-0.53	0.65	0.66	0.56	-0.71	0.91		0.91	0.75	-0.65	-0.33	-0.48	0.75	-0.4	0.44	0.95	0.6	-0.75	0.62	-0.27	-0.01
Net Income	-0.8	-0.7	-0.53	-0.47	-0.73	0.91	0.91	0.85	-0.93	1.0	0.91		0.8	-0.9	-0.49	-0.56	0.8	-0.59	0.62	0.99	0.85	-0.81	0.76	-0.39	-0.14
Income Tax Expense	-0.68	-0.6	-0.41	-0.19	-0.61	0.76	0.77	0.72	-0.76	0.83	0.75	0.8		-0.74	-0.41	-0.36	1.0	-0.33	0.52	0.79	0.71	-0.68	0.6	-0.4	-0.26
Selling General Administrative	0.68	0.71	0.49	0.38	0.73	-0.98	-0.97	-0.97	0.96	-0.9	-0.65	-0.9	-0.74		0.46	0.52	-0.74	0.68	-0.6	-0.84	-0.91	0.69	-0.74	0.36	0.29
Cost Of Revenue	0.84	0.94	0.99	0.36	0.94	-0.6	-0.61	-0.47	0.64	-0.49	-0.33	-0.49	-0.41	0.46		0.73	-0.42	-0.01	-0.98	-0.43	-0.74	0.83	-0.55	0.95	0.42
Selling And Marketing Expenses	0.81	0.7	0.79	0.7	0.77	-0.54	-0.56	-0.41	0.66	-0.56	-0.48	-0.56	-0.36	0.52	0.73		-0.36	0.06	-0.73	-0.49	-0.58	0.82	-0.45	0.75	0.49
Tax Provision	-0.68	-0.61	-0.42	-0.18	-0.61	0.76	0.77	0.72	-0.75	0.82	0.75	0.8	1.0	-0.74	-0.42	-0.36		-0.32	0.52	0.79	0.72	-0.68	0.6	-0.41	-0.26
Interest Income	0.21	0.2	0.03	0.22	0.26	-0.65	-0.65	-0.73	0.59	-0.58	-0.4	-0.59	-0.33	0.68	-0.01	0.06	-0.32		-0.1	-0.57	-0.51	0.23	-0.77	-0.22	-0.01
Net Interest Income	-0.88	-0.98	-0.97	-0.37	-0.98	0.72	0.73	0.6	-0.75	0.62	0.44	0.62	0.52	-0.6	-0.98	-0.73	0.52	-0.1		0.57	0.84	-0.87	0.61	-0.92	-0.38
Net Income From Continuing Ops	-0.78	-0.64	-0.48	-0.46	-0.67	0.85	0.85	0.78	-0.87	0.99	0.95	0.99	0.79	-0.84	-0.43	-0.49	0.79	-0.57	0.57		0.8	-0.79	0.74	-0.34	-0.08
Research Development	-0.84	-0.91	-0.75	-0.41	-0.91	0.96	0.96	0.91	-0.96	0.85	0.6	0.85	0.71	-0.91	-0.74	-0.58	0.72	-0.51	0.84	0.8		-0.83	0.77	-0.65	-0.4
Reconciled Depreciation	1.0	0.87	0.88	0.68	0.92	-0.76	-0.77	-0.61	0.85	-0.81	-0.75	-0.81	-0.68	0.69	0.83	0.82	-0.68	0.23	-0.87	-0.79	-0.83		-0.7	0.81	0.49
Minority Interest	-0.69	-0.65	-0.58	-0.39	-0.71	0.8	0.82	0.78	-0.79	0.76	0.62	0.76	0.6	-0.74	-0.55	-0.45	0.6	-0.77	0.61	0.74	0.77	-0.7		-0.35	-0.21
Discontinued Operations	0.82	0.88	0.95	0.41	0.87	-0.48	-0.49	-0.33	0.56	-0.4	-0.27	-0.39	-0.4	0.36	0.95	0.75	-0.41	-0.22	-0.92	-0.34	-0.65	0.81	-0.35		0.56
Extraordinary Items	0.49	0.39	0.5	0.66	0.45	-0.28	-0.29	-0.19	0.41	-0.15	-0.01	-0.14	-0.26	0.29	0.42	0.49	-0.26	-0.01	-0.38	-0.08	-0.4	0.49	-0.21	0.56

Click cells to compare fundamentals

Auxly Cannabis Account Relationship Matchups

Auxly Cannabis income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	8.6M	9.0M	14.3M	21.6M	11.2M	11.8M
Interest Expense	12.1M	13.0M	17.7M	21.6M	25.7M	26.9M
Total Revenue	8.4M	50.8M	83.8M	94.5M	101.1M	106.1M
Gross Profit	(3.7M)	11.1M	19.3M	17.9M	(1.9M)	(1.8M)
Other Operating Expenses	70.9M	97.9M	122.8M	142.0M	143.2M	150.4M
Operating Income	(61.0M)	(54.0M)	(42.0M)	(46.8M)	(42.2M)	(40.0M)
Ebit	(61.0M)	(53.7M)	(42.0M)	(46.8M)	(42.2M)	(40.0M)
Ebitda	(52.5M)	(44.6M)	(27.7M)	(25.2M)	(30.9M)	(29.4M)
Total Operating Expenses	58.9M	58.2M	58.2M	65.5M	40.3M	42.3M
Income Before Tax	(119.6M)	(88.1M)	(50.2M)	(136.6M)	(47.7M)	(45.4M)
Total Other Income Expense Net	(58.6M)	(34.1M)	(8.2M)	(89.8M)	(5.6M)	(5.9M)
Net Income	(108.6M)	(87.4M)	(45.9M)	(130.3M)	(44.5M)	(42.3M)
Income Tax Expense	(11.0M)	(681K)	(4.3M)	(6.3M)	(3.2M)	(3.1M)
Selling General Administrative	50.0M	43.2M	36.1M	37.5M	31.8M	19.5M
Cost Of Revenue	12.1M	39.7M	64.5M	76.6M	103.0M	108.1M
Selling And Marketing Expenses	398K	274K	5.6M	9.6M	13.1M	5.1M
Tax Provision	(11.0M)	(681K)	(4.3M)	(6.3M)	(3.2M)	(3.4M)
Interest Income	12.1M	20.4M	3.9M	337K	32K	30.4K
Net Income Applicable To Common Shares	(102.6M)	(85.4M)	(33.7M)	(130.3M)	(117.3M)	(111.4M)
Net Interest Income	(8.5M)	(12.6M)	(16.1M)	(21.2M)	(25.7M)	(24.4M)
Net Income From Continuing Ops	(108.6M)	(87.4M)	(45.9M)	(130.3M)	(44.5M)	(46.7M)
Reconciled Depreciation	8.6M	9.4M	14.3M	21.6M	11.2M	10.5M

Pair Trading with Auxly Cannabis

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Auxly Cannabis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Auxly Cannabis will appreciate offsetting losses from the drop in the long position's value.

Moving against Auxly Stock

0.6	BRY	Bri Chem Corp	Pair Corr
0.53	SEC	Senvest Capital	Pair Corr
0.53	ERE-UN	European Residential Real	Pair Corr
0.51	AAPL	Apple Inc CDR	Pair Corr
0.5	LB	Laurentian Bank	Pair Corr

The ability to find closely correlated positions to Auxly Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Auxly Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Auxly Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Auxly Cannabis Group to buy it.

The correlation of Auxly Cannabis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Auxly Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Auxly Cannabis Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Auxly Cannabis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Auxly Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Auxly Historical Income Statement

About Auxly Income Statement Analysis

Auxly Cannabis Income Statement Chart

Total Revenue

Other Operating Expenses

Total Operating Expenses

Interest Income

Auxly Cannabis income statement Correlations

Auxly Cannabis Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Auxly Cannabis income statement Accounts

Pair Trading with Auxly Cannabis

Moving against Auxly Stock

Other Information on Investing in Auxly Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Ebit	+ 1.0	Operating Income
Net Income	+ 1.0	Income Before Tax
Tax Provision	+ 1.0	Income Tax Expense
Other Operating Expenses	+ 0.99	Interest Expense
Cost Of Revenue	+ 0.99	Total Revenue

Net Interest Income	- 0.98	Cost Of Revenue
Total Operating Expenses	- 0.98	Ebit
Selling General Administrative	- 0.98	Operating Income
Total Operating Expenses	- 0.98	Operating Income
Net Interest Income	- 0.98	Other Operating Expenses
Net Interest Income	- 0.98	Interest Expense